{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-008694","form_type":"8-K","ticker":"PTCT","cik":"0001070081","company_name":"PTC THERAPEUTICS, INC.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.412062+00:00","generated_at":"2026-05-19T04:10:51.568176+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"PTC Therapeutics reports results of 2025 annual meeting; all three proposals approved","bullets":["Elected Allan Jacobson (60,386,986 for), David Southwell (59,200,375), Alethia Young (54,894,657) as Class III directors to 2028 term.","Ratified Ernst & Young as independent auditor for FY 2025: 67,259,475 for, 195,233 against, 21,362 abstained.","Approved non-binding advisory vote on executive compensation: 60,479,157 for, 1,979,310 against, 44,711 abstained."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-008694","json":"https://secwatch.observer/filing/0001558370-25-008694.json","markdown":"https://secwatch.observer/filing/0001558370-25-008694.md","text":"https://secwatch.observer/filing/0001558370-25-008694.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070081/000155837025008694/0001558370-25-008694-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070081/000155837025008694/tmb-20250617x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:10:51.568176+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}